{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:50:23Z","timestamp":1788871823220,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.cbi.2012.11.023","type":"journal-article","created":{"date-parts":[[2012,12,14]],"date-time":"2012-12-14T10:02:40Z","timestamp":1355479360000},"page":"126-135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Regulation of human carbonyl reductase 1 (CBR1, SDR21C1) gene by transcription factor Nrf2"],"prefix":"10.1016","volume":"202","author":[{"given":"Takeshi","family":"Miura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Taketomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Nishinaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2012.11.023_b0005","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2174\/138920010794233530","article-title":"Human carbonyl reductases","volume":"11","author":"Mal\u00e1tkoiv\u00e1","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.cbi.2012.11.023_b0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cbi.2008.10.058","article-title":"The human short-chain dehydrogenase\/reducatase (SDR) superfamily: a bioinformatics summary","volume":"178","author":"Bray","year":"2009","journal-title":"Chem-Biol. Interact."},{"key":"10.1016\/j.cbi.2012.11.023_b0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/03602530600969440","article-title":"Carbonyl reductases and pluripotent hydroxy steroid dehydrogenases of the short-chain dehydrogenase\/reductase superfamily","volume":"39","author":"Hoffmann","year":"2007","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.cbi.2012.11.023_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2133\/dmpk.21.1","article-title":"Multiplicity of mammalian reductases for xenobiotic carbonyl compounds","volume":"21","author":"Matsunaga","year":"2006","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.cbi.2012.11.023_b0025","doi-asserted-by":"crossref","first-page":"16185","DOI":"10.1016\/S0021-9258(18)37576-8","article-title":"Human carbonyl reductase. Nucleotide sequence analysis of a cDNA and amino acid sequence of the encoded protein","volume":"263","author":"Wermuth","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2012.11.023_b0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/geno.1998.5380","article-title":"Mapping of a novel human carbonyl reductase, CBR3, and ribosomal pseudogenes to human chromosome 21q22.2","volume":"51","author":"Watanabe","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.cbi.2012.11.023_b0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11010-008-9794-5","article-title":"Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1","volume":"315","author":"Miura","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cbi.2012.11.023_b0040","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.bbrc.2008.11.003","article-title":"Human carbonyl reductase 4 is a mitochondrial NADPH-dependent quinone reductase","volume":"377","author":"Endo","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2012.11.023_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2009.06.005","article-title":"Importance of the substrate-binding loop region of human monomeric carbonyl reductases in catalysis and coenzyme binding","volume":"85","author":"Miura","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2012.11.023_b0050","doi-asserted-by":"crossref","first-page":"e7113","DOI":"10.1371\/journal.pone.0007113","article-title":"Structural basis for substrate specificity in human monomeric carbonyl reductases","volume":"4","author":"Pilka","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cbi.2012.11.023_b0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cbi.2008.11.004","article-title":"Analysis of the substrate-binding site of human carbonyl reductases CBR1 and CBR3 by site-directed mutagenesis","volume":"178","author":"El-Hawari","year":"2009","journal-title":"Chem-Biol. Interact."},{"key":"10.1016\/j.cbi.2012.11.023_b0060","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S0021-9258(19)69950-3","article-title":"Purification and properties of an NADPH-dependent carbonyl reductase from human brain. Relationship to prostaglandin 9-keto reductase and xenobiotic ketone reductase","volume":"256","author":"Wermuth","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2012.11.023_b0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2012.03.035","article-title":"Decreased carbonyl reductase 1 expression promotes malignant behaviours by induction of epithelial mesenchymal transition and its clinical significance","volume":"323","author":"Murakami","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cbi.2012.11.023_b0070","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1158\/1535-7163.MCT-06-0722","article-title":"Clofibric acid, a peroxisome proliferator-activated receptor ligand, inhibits growth of human ovarian cancer","volume":"6","author":"Yokoyama","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cbi.2012.11.023_b0075","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1158\/1055-9965.EPI-05-0060","article-title":"Carbonyl reductase expression and its clinical significance in non-small-cell lung cancer","volume":"14","author":"Takenaka","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.cbi.2012.11.023_b0080","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1124\/dmd.108.022251","article-title":"Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver","volume":"36","author":"Kassner","year":"2008","journal-title":"Drug Metab. Disp."},{"key":"10.1016\/j.cbi.2012.11.023_b0085","first-page":"502","article-title":"Genomic sequence and expression of a cloned human carbonyl reductase gene with daunorubicin reductase activity","volume":"40","author":"Forrest","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2012.11.023_b0090","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CAD.0b013e3283512726","article-title":"Sex differences in improved efficacy of doxorubicin chemotherapy in Cbr1+\/\u2212 mice","volume":"23","author":"Freeland","year":"2012","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.cbi.2012.11.023_b0095","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.23723","article-title":"Carbonyl reductase 1 as a novel target of (\u2212)-epigallocatechin gallate against hepatocellular carcinoma","volume":"52","author":"Huang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2012.11.023_b0100","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1007\/s11095-008-9592-5","article-title":"Inhibition of polymorphic human carbonyl reductase 1 (CBR1) by the cardioprotectant flavonoid 7-monohydroxyethyl rutoside (monoHER)","volume":"25","author":"Gonzalez-Covarrubias","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.cbi.2012.11.023_b0105","first-page":"6602","article-title":"Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1","volume":"63","author":"Olson","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2012.11.023_b0110","first-page":"5158","article-title":"Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice","volume":"60","author":"Forrest","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2012.11.023_b0115","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1046\/j.0014-2956.2001.02510.x","article-title":"Characterization of a major form of human isatin reductase and the reduced metabolite","volume":"268","author":"Usami","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.cbi.2012.11.023_b0120","first-page":"87","article-title":"Isatin, an endogenous MAO inhibitor, and a rat model of Parkinson\u2019s disease induced by the Japanese encephalitis virus","volume":"71","author":"Minami","year":"2006","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.cbi.2012.11.023_b0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0161-813X(03)00100-1","article-title":"Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson\u2019s disease induced by the Japanese encephalitis virus","volume":"25","author":"Hamaue","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.cbi.2012.11.023_b0130","first-page":"395","article-title":"Significance of isatin, an endogenous MAO inhibitor, on blood pressure control and monoamine level in rats","volume":"12","author":"Hamaue","year":"1997","journal-title":"Biogenic Amines"},{"key":"10.1016\/j.cbi.2012.11.023_b0135","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/mol.107.035550","article-title":"Functional characterization of the promoter of human carbonyl reductase 1 (CBR1). Role of XRE elements in mediating the induction of CBR1 by ligands of the aryl hydrocarbon receptor","volume":"72","author":"Lakhman","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2012.11.023_b0140","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.toxlet.2012.04.006","article-title":"Induction of carbonyl reductase 1 (CBR1) expression in human lung tissues and lung cancer cells by the cigarette smoke constituent benzo[a]pyrene","volume":"211","author":"Kalabus","year":"2012","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2012.11.023_b0145","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jhep.2010.06.045","article-title":"Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells","volume":"54","author":"Tak","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cbi.2012.11.023_b0150","unstructured":"M. Jang, Y. Kim, H. Won, S. Lim, J.K. R, A. Dashdorj, Y.H. Min, S.Y. Kim, K.M. Shokat, J. Ha, S.S. Kim, Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide, Cancer Res. (in press)."},{"key":"10.1016\/j.cbi.2012.11.023_b0155","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cbi.2008.10.006","article-title":"Chinese hamster monomeric carbonyl reductases of the short-chain dehydrogenase\/reductase superfamily","volume":"178","author":"Miura","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2012.11.023_b0160","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.1093\/nar\/16.15.7351","article-title":"A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions","volume":"16","author":"Higuchi","year":"1988","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2012.11.023_b0165","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1074\/jbc.M000361200","article-title":"Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK","volume":"275","author":"Nguyen","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2012.11.023_b0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1254\/jphs.FP0040404","article-title":"Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene","volume":"97","author":"Nishinaka","year":"2005","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2012.11.023_b0175","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/mol.107.035550","article-title":"Functional characterization of the promoter of human carbonyl reductase 1 (CBR1). Role of XRE elements in mediating the induction of CBR1 by ligands of the aryl hydrocarbon receptor","volume":"72","author":"Lakhman","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2012.11.023_b0180","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.leu.2402880","article-title":"Optimization of quantitative real-time RT-PCR parameters for the study of lymphoid malignancies","volume":"17","author":"Lossos","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.cbi.2012.11.023_b0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.cbi.2008.10.005","article-title":"Investigation of the role of the amino acid residue at position 230 for catalysis in monomeric carbonyl reductase 3","volume":"178","author":"Miura","year":"2009","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2012.11.023_b0190","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2012.11.023_b0195","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2012.11.023_b0200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.toxlet.2007.03.011","article-title":"Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element","volume":"170","author":"Nishinaka","year":"2007","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2012.11.023_b0205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.cbi.2011.01.026","article-title":"Regulation of aldo-keto reductase AKR1B10 gene expression: involvement of transcriptional factor Nrf2","volume":"191","author":"Nishinaka","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2012.11.023_b0210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0167-4781(90)90050-C","article-title":"Induction of a human carbonyl reductase gene located on chromosome 21","volume":"1048","author":"Forrest","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2012.11.023_b0215","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1101\/gad.1026202","article-title":"The RNA polymerase II core promoter: a key component in the regulation of gene expression","volume":"16","author":"Butler","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.cbi.2012.11.023_b0220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/bst0280033","article-title":"The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin","volume":"28","author":"Hayes","year":"2000","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.cbi.2012.11.023_b0225","first-page":"3299","article-title":"The Cap\u2019n\u2019Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes","volume":"61","author":"McMahon","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.cbi.2012.11.023_b0230","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1042\/BJ20051518","article-title":"Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene","volume":"395","author":"Vollrath","year":"2006","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2012.11.023_b0235","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/mc.20234","article-title":"Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells","volume":"45","author":"Yuan","year":"2006","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.cbi.2012.11.023_b0240","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/hmg\/ddm066","article-title":"Identification of polymorphic antioxidant response elements in the human genome","volume":"16","author":"Wang","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cbi.2012.11.023_b0245","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0092-8674(87)90611-8","article-title":"Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor","volume":"49","author":"Angel","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2012.11.023_b0250","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1126\/science.2825349","article-title":"Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1","volume":"238","author":"Bohmann","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.cbi.2012.11.023_b0255","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/0092-8674(87)90612-X","article-title":"Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements","volume":"49","author":"Lee","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.cbi.2012.11.023_b0260","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0009-2797(02)00208-9","article-title":"Further characterization of Chinese hamster carbonyl reductases (CHCRs)","volume":"143\u2013144","author":"Terada","year":"2003","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2012.11.023_b0265","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-1-60761-738-9_3","article-title":"Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents","volume":"647","author":"Giudice","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cbi.2012.11.023_b0270","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cbi.2010.12.006","article-title":"The Drosophila carbonyl reductase sniffer is an efficient 4-oxonon-2-enal (4ONE) reductase","volume":"191","author":"Martin","year":"2011","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2012.11.023_b0275","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.freeradbiomed.2010.08.015","article-title":"Carbonyl reductase 1 protects pancreatic b-cells against oxidative stress-induced apoptosis in glucotoxicity and glucolipotoxicity","volume":"49","author":"Rashid","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2012.11.023_b0280","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1105351","article-title":"BEAM study investigators, Bardoxolone methyl and kidney function in CKD with type 2 diabetes","volume":"365","author":"Perqola","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cbi.2012.11.023_b0285","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1158\/1078-0432.CCR-11-2703","article-title":"A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas","volume":"18","author":"Hong","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cbi.2012.11.023_b0290","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2008.12.012","article-title":"Moxonidine prevents ischemia\/reperfusion-induced renal injury in rats","volume":"603","author":"Tsutsui","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2012.11.023_b0295","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejphar.2003.09.036","article-title":"The role of renal sympathetic nervous system in the pathogenesis of ischemic acute renal failure","volume":"481","author":"Fujii","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2012.11.023_b0300","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/hr.2010.35","article-title":"The role of sympathetic nervous activity in renal injury and end-stage renal disease","volume":"33","author":"Masuo","year":"2010","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.cbi.2012.11.023_b0305","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1254\/jphs.08R09FM","article-title":"Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD","volume":"109","author":"Tanaka","year":"2009","journal-title":"J. Pharmacol. Sci."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279712002670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279712002670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:44:39Z","timestamp":1762112679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279712002670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":61,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0009279712002670"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2012.11.023","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of human carbonyl reductase 1 (CBR1, SDR21C1) gene by transcription factor Nrf2","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2012.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}